Cargando…

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccina...

Descripción completa

Detalles Bibliográficos
Autores principales: Castilla, Jesús, Navascués, Ana, Casado, Itziar, Pérez-García, Alejandra, Aguinaga, Aitziber, Ezpeleta, Guillermo, Pozo, Francisco, Ezpeleta, Carmen, Martínez-Baz, Iván
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824126/
https://www.ncbi.nlm.nih.gov/pubmed/29471624
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.7.18-00057
_version_ 1783301988700651520
author Castilla, Jesús
Navascués, Ana
Casado, Itziar
Pérez-García, Alejandra
Aguinaga, Aitziber
Ezpeleta, Guillermo
Pozo, Francisco
Ezpeleta, Carmen
Martínez-Baz, Iván
author_facet Castilla, Jesús
Navascués, Ana
Casado, Itziar
Pérez-García, Alejandra
Aguinaga, Aitziber
Ezpeleta, Guillermo
Pozo, Francisco
Ezpeleta, Carmen
Martínez-Baz, Iván
author_sort Castilla, Jesús
collection PubMed
description The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccination only, and 22% for any prior doses, and 43%, 51% and 54%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B.
format Online
Article
Text
id pubmed-5824126
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-58241262018-09-04 Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18 Castilla, Jesús Navascués, Ana Casado, Itziar Pérez-García, Alejandra Aguinaga, Aitziber Ezpeleta, Guillermo Pozo, Francisco Ezpeleta, Carmen Martínez-Baz, Iván Euro Surveill Rapid Communication The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccination only, and 22% for any prior doses, and 43%, 51% and 54%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B. European Centre for Disease Prevention and Control (ECDC) 2018-02-15 /pmc/articles/PMC5824126/ /pubmed/29471624 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.7.18-00057 Text en This article is copyright of The Authors, 2018. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Castilla, Jesús
Navascués, Ana
Casado, Itziar
Pérez-García, Alejandra
Aguinaga, Aitziber
Ezpeleta, Guillermo
Pozo, Francisco
Ezpeleta, Carmen
Martínez-Baz, Iván
Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
title Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
title_full Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
title_fullStr Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
title_full_unstemmed Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
title_short Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
title_sort interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza b, northern spain, 2017/18
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824126/
https://www.ncbi.nlm.nih.gov/pubmed/29471624
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.7.18-00057
work_keys_str_mv AT castillajesus interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718
AT navascuesana interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718
AT casadoitziar interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718
AT perezgarciaalejandra interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718
AT aguinagaaitziber interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718
AT ezpeletaguillermo interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718
AT pozofrancisco interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718
AT ezpeletacarmen interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718
AT martinezbazivan interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718
AT interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718
AT interimeffectivenessoftrivalentinfluenzavaccineinaseasondominatedbylineagemismatchedinfluenzabnorthernspain201718